What this fund achieved
Your support made it possible to reach people with lifesaving tools like diagnostics and vaccines, while supporting research and development to rapidly identify new innovations like therapeutics.
The impact you’ve helped influence
$18M invested to purchase COVID-19 vaccine doses for low-income countries through Gavi’s COVAX Advance Market Commitment.
5,000 diagnostics instruments have been sent to 49 countries around the world, expanding testing capabilities for COVID-19. Manufacturing capacity of this platform will scale to produce 150 million tests per year from 2022-2030.
In the hunt to find an effective treatment against COVID-19, scientists analyzed more than 10,000 compounds to find a match.
50 grants totaling over $128M were made to high-impact projects. These projects helped develop new tools for a sustained response, protect the most vulnerable populations, and ensure the equitable, timely delivery of lifesaving products.